Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Preclinical investigation of Deep Brain Stimulation for the treatment of Epilepsy
FY 2022-23
Summary
Epilepsy is a brain disorder characterized by the propensity for recurrent unprovoked seizures that affects 2% of children. Children with drug-resistant epilepsy (DRE) continue to experience debilitating seizures despite the best available treatments and may benefit from surgery. Deep brain stimulation (DBS) is a neuromodulation technique involving surgically inserted electrodes that deliver electrical impulses to targeted brain structures. DBS of the centromedian nucleus of the thalamus (CM-DBS) is currently being explored as a novel treatment for children with DRE with promising results. However, its mechanisms of action are poorly understood, and it is unclear which patient is most likely to benefit from surgery. There is an unmet need to develop preclinical studies to better understand the neurobiological underpinnings of CM-DBS.
In our proposed study, we will employ a mouse model of epilepsy to investigate whether CM-DBS reduces the frequency and intensity of seizures, prevents epilepsy-related behavioural abnormalities, and induces beneficial alterations to brain morphology.
Seizures will be induced in mice and the effects of CM-DBS on the severity of the epilepsy, relative to a sham surgery control will be studied. Additionally, behavioral tests will be conducted to assess memory, anxiety, compulsive, and depressive-like behaviors following CM-DBS. Lastly, the recovered brains will be studied with magnetic resonance imaging and histology to study alterations in brain regions associated with DBS effects.
The results from this study will provide valuable insight on the neurobiological properties underlying CM-DBS. These findings will help us better understand the mechanisms of action of CM-DBS and facilitate the development of personalized treatment strategies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
485935
Name
Matin Rafi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Preclinical investigation of Deep Brain Stimulation for the treatment of Epilepsy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Centromedian Nucleus Of The Thalamus; Deep Brain Stimulation; Mouse Model; Neuromodulation; Ptz-Kindling Mouse Model; Refractory Epilepsy
Abstract
Epilepsy is a brain disorder characterized by the propensity for recurrent unprovoked seizures that affects 2% of children. Children with drug-resistant epilepsy (DRE) continue to experience debilitating seizures despite the best available treatments and may benefit from surgery. Deep brain stimulation (DBS) is a neuromodulation technique involving surgically inserted electrodes that deliver electrical impulses to targeted brain structures. DBS of the centromedian nucleus of the thalamus (CM-DBS) is currently being explored as a novel treatment for children with DRE with promising results. However, its mechanisms of action are poorly understood, and it is unclear which patient is most likely to benefit from surgery. There is an unmet need to develop preclinical studies to better understand the neurobiological underpinnings of CM-DBS.
In our proposed study, we will employ a mouse model of epilepsy to investigate whether CM-DBS reduces the frequency and intensity of seizures, prevents epilepsy-related behavioural abnormalities, and induces beneficial alterations to brain morphology.
Seizures will be induced in mice and the effects of CM-DBS on the severity of the epilepsy, relative to a sham surgery control will be studied. Additionally, behavioral tests will be conducted to assess memory, anxiety, compulsive, and depressive-like behaviors following CM-DBS. Lastly, the recovered brains will be studied with magnetic resonance imaging and histology to study alterations in brain regions associated with DBS effects.
The results from this study will provide valuable insight on the neurobiological properties underlying CM-DBS. These findings will help us better understand the mechanisms of action of CM-DBS and facilitate the development of personalized treatment strategies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Matin, Rafi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~